Results 181 to 190 of about 11,782,455 (235)

Delayed Argon Plasma Coagulation After Endoscopic Injection Sclerotherapy for Esophageal Varices Reduces Recurrence Risk

open access: yesDEN Open, Volume 7, Issue 1, April 2027.
ABSTRACT Objectives Argon plasma coagulation (APC) is commonly used as consolidation therapy after endoscopic injection sclerotherapy (EIS) for esophageal varices (EVs); however, the optimal timing of APC remains unclear. This study evaluated the association between the EIS–APC interval and clinical outcomes.
Takumi Yanagita   +16 more
wiley   +1 more source

An Anatomist's View on the Crosstalk Between the Liver and the Lung

open access: yesComprehensive Physiology, Volume 16, Issue 6, December 2026.
The liver and the lung have a similar three‐dimensional and cellular architecture as well as functional communalities. The structural, functional, and pathophysiological interplay between both organs suggests the existence of an interorgan axis, the liver‐lung axis. Created in biorender.com.
Tanja Kloock   +2 more
wiley   +1 more source

Dynamic Changes in Metabolic Syndrome and Risk of Hepatocellular Carcinoma: Evidence From a Nationwide Japanese Cohort

open access: yesLiver International Communications, Volume 7, Issue 4, December 2026.
ABSTRACT Aim Metabolic syndrome (MetS) is a known risk factor for hepatocellular carcinoma (HCC), but the impact of cumulative MetS burden and changes in MetS status over time remains unclear. This study aimed to assess these associations using a large‐scale Japanese health dataset.
Yutaka Yata   +9 more
wiley   +1 more source

Farnesoid X Receptor Agonist INT‐787 Protects Human Liver Organoids From Alcohol‐Induced Injury

open access: yesLiver International Communications, Volume 7, Issue 4, December 2026.
ABSTRACT Background Alcohol‐associated liver disease (ALD) represents a spectrum of liver injury ranging from steatosis to alcohol‐associated hepatitis, cirrhosis, and hepatocellular carcinoma. Activation of the farnesoid X receptor (FXR) decreases liver steatosis, inflammation, and fibrosis in animal models of liver‐related diseases, including ...
Francesca De Franco   +8 more
wiley   +1 more source

Diagnostic Performance of Magnetic Resonance Elastography Versus Vibration‐Controlled Transient Elastography for Liver Fibrosis Staging in Steatotic Liver Disease

open access: yesNMR in Biomedicine, Volume 39, Issue 12, December 2026.
In 91 patients, vibration‐controlled transient elastography, two‐dimensional acoustic magnetic resonance elastography, and two‐ and three‐dimensional gravitational magnetic resonance elastography were compared for liver fibrosis assessment, with 35 biopsy‐confirmed cases.
Leon David Gruenewald   +26 more
wiley   +1 more source

Ageing, women's health and personalised medicine: Advancing artificial intelligence and therapeutics through the blueprint theory paradigm

open access: yes
Experimental Physiology, EarlyView.
Rosie Richardson   +4 more
wiley   +1 more source

Vibration‐Controlled Transient Elastography (VCTE)‐Based Prevalence and Assessment of Hepatic Steatosis and Fibrosis in a UK Tertiary Hospital‐Based Specialist Weight Management Service: A Real‐World Evaluation

open access: yesObesity Science &Practice, Volume 12, Issue 6, December 2026.
ABSTRACT Background Metabolic dysfunction‐associated steatotic liver disease is common in severe obesity; however, liver health assessment is inconsistently implemented in specialist weight management services and real‐world data are scarce. This study evaluated the prevalence and severity of vibration‐controlled transient elastography (VCTE)‐defined ...
Scott A. Willis   +7 more
wiley   +1 more source

DUCK‐Net: automated deep learning segmentation of ductular reactions in murine liver injury captures multicellular niche dynamics from H&E morphology

open access: yesThe Journal of Pathology, Volume 270, Issue 4, Page 441-454, December 2026.
Abstract Ductular reactions (DRs) are dynamic and complex multicellular responses that occur as a result of various hepatic injuries. Precise identification and quantification of the extent of DRs is a cornerstone of pre‐clinical modelling of liver disease, with links to inflammation, fibrosis, regeneration, and disease severity.
Nathalie Feeley   +15 more
wiley   +1 more source

Therapies for Cardiovascular‐Kidney‐Liver‐Metabolic Syndrome: Reappraisal of Fibrates

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 12, Page 10931-10949, December 2026.
ABSTRACT Cardiovascular disease, chronic kidney disease (CKD), type 2 diabetes mellitus (T2DM), obesity and metabolic dysfunction‐associated steatohepatitis (MASH) frequently coexist and share overlapping pathophysiology, forming the proposed cardiovascular‐kidney‐liver‐metabolic (CKLM) syndrome.
Virginia Anagnostopoulou   +5 more
wiley   +1 more source

Real‐World Cost and Utilisation Burden of Diagnosed Metabolic Dysfunction‐Associated Steatotic Liver Disease in Patients With Type 2 Diabetes in the United States: A Retrospective Cohort Study

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 12, Page 11394-11406, December 2026.
ABSTRACT Aims This study quantified the real‐world healthcare costs and utilisation associated with diagnosed metabolic dysfunction‐associated steatotic liver disease (MASLD) among adults with Type 2 diabetes (T2D). Methods We conducted a retrospective cohort study using IQVIA PharMetrics Plus Closed Health Plan data from January 2016 to June 2025 ...
Tien Hoang Tran   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy